Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib + CHOP in Advanced T-Cell or NK/T-Cell Lymphomas
NCT00374699Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Apr 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in peripheral T-cell lymphoma (PTCL), Natural killer T-cell lymphoma (NKTL), sponsored by Samsung Medical Center. Started Apr 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
peripheral T-cell lymphoma (PTCL)Natural killer T-cell lymphoma (NKTL)
Beyond the preview
Go deeper on NCT00374699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374699.